<?xml version="1.0" encoding="utf-8"?>
<oembed>
  <version>1</version>
  <type>rich</type>
  <provider_name>Libsyn</provider_name>
  <provider_url>https://www.libsyn.com</provider_url>
  <height>90</height>
  <width>600</width>
  <title>Tumor Infiltrating Lymphocyte (TIL) Therapies in Melanoma, How’s It Going and What Is Next?</title>
  <description>On this episode of SurgOnc Today, Dr. Amanda Kirane and Dr. Allison Betof discuss the clinical application of TIL therapy for melanoma patients, including the comprehensive care and teamwork required. They also discuss lessons learned and newer clinical trials optimizing the therapy. </description>
  <author_name>SurgOnc Today®</author_name>
  <author_url>http://surgonctoday.libsyn.com/website</author_url>
  <html>&lt;iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/41534915/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/88AA3C/" height="90" width="600" scrolling="no"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen&gt;&lt;/iframe&gt;</html>
  <thumbnail_url>https://assets.libsyn.com/secure/content/202618180</thumbnail_url>
</oembed>
